Jan Muselík

Jan Muselík

Auto-generated profile, based on publicly available information

Jan Muselík

Faculty of Pharmacy Masaryk University Brno Czech Republic

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
PVPavlína Vodáčková
Pavlína Vodáčková
BVBarbora Vraníková
Barbora Vraníková
PSPetra Svačinová
Petra Svačinová
AFAleš Franc
Aleš Franc
JEJan Elbl
Jan Elbl
TSTomaš Solný
Tomaš Solný
As coprocessed excipients (CPE) gain a lot of focus recently, this article compares three commercially available CPE of Avicel brand, namely, CE 15, DG, and HFE 102. Comparison is based on measured physical properties of coprocessed mixtures, respectively, flow properties, pycnometric density, mean particle size, specific surface area, moisture content, hygroscopicity, solubility, pH leaching, electrostatic charge, SEM images, and DSC. Tablets were made employing three pressure sets. Viscoelastic properties and ejection force were assessed during compression, as well as pycnometric density, mass uniformity, height, tensile strength, friability, disintegration, and wetting times. Avicel CE 15 is of mid-range flow properties, contains mid-size and nonspherical particles, and has high hygroscopicity, growing negative charge, best lubricity, lowest tensile strength, and mid-long disintegration times. Avicel DG possesses the worst flow properties, small asymmetrical particles, lowest hygroscopicity, stable charge, intermediate lubricity, and tensile strength and exhibits fast disintegration of tablets. Finally, Avicel HFE 102 has the best flow properties, large symmetrical particles, and middle hygroscopicity and its charge fluctuates throughout blending. It also exhibits inferior lubricity, the highest tensile strength, and slow disintegration of tablets. Generally, it is impossible to select the best CPE, as their different properties fit versatile needs of countless manufacturers and final products.

1 April 2019 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SPSylvie Pavloková
Sylvie Pavloková
JMJan Muselík
Jan Muselík
DSDana Sabadková
Dana Sabadková
SBSilvie Bernatová
Silvie Bernatová
OSOta Samek
Ota Samek
AFAleš Franc
Aleš Franc

21 June 2019 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
VTVeronika Nováková Tkadlečková
Veronika Nováková Tkadlečková
Jakub VysloužilJakub Vysloužil
Jakub Vysloužil
KKKaterina Kubova
Katerina Kubova
JEJan Elbl
Jan Elbl
DBDarja Bučková
Darja Bučková
PPPetr Poláček
Petr Poláček
In veterinary medicine, vaginal rings (VRs) are rarely used. However, there are diseases of female dogs’ reproductive system which represent a suitable possibility for their usage. An example of such a disease is canine pyometra which can be treated by lipophilic prostaglandin drugs, unfortunately with harmful side effects after systemic administration. The aim of the study was to prove that the matrix VR based on silicone and channel-forming substance can be successfully used as a carrier for a three-day delivery of prostaglandin E2 (PGE2). Based on an in-vitro release study, an optimum channel-forming substance and its concentration were selected. The results were implemented during the construction of VR from the medical grade silicone DDU-4840 with PGE2 (5 mg). Glucose anhydrous in the 30% concentration was chosen as the most functional channel-forming substance due to synergism of osmotic activity and solubility. The DDU-VR containing PGE2 and 30% of glucose anhydrous exhibited excellent mechanical characteristics and ensured 29% drug release through water-filled channels in first-order kinetic manner. This is eight times higher than a sample without glucose where molecular diffusion through the silicone matrix was dominating the release mechanism. Moreover, drug-free VRs were tested for mechanical resistance and the design of removal thread.

9 May 2025 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
JMJan Muselík
Jan Muselík
AKAlena Komersová
Alena Komersová
JEJan Elbl
Jan Elbl
RSRoman Svoboda
Roman Svoboda
KMKevin Matzick
Kevin Matzick
AFAleš Franc
Aleš Franc

20 June 2025 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
AFAleš Franc
Aleš Franc
BŽBořek Žaludek
Bořek Žaludek
PSPetr Sova
Petr Sova
RGRoman Goněc
Roman Goněc
JMJan Muselík
Jan Muselík

15 December 2018 in Praktické lékárenství
Verified
Journal Article
Open access
PDF file
AFAleš Franc
Aleš Franc
JEJan Elbl
Jan Elbl
JMJan Muselík
Jan Muselík
KKKaterina Kubova
Katerina Kubova
DVDavid Vetchý
David Vetchý
V současné době existují v celém v světě miliony lidí závislých na benzodiazepinech. Forma somatické i psychické závislosti znemožňuje okamžité vysazení léčiv. Jedním z dlouhodobě osvědčených léčebných postupů je převedení pacientů na diazepam, který má dlouhý biologický poločas. Po stabilizaci následuje postupné snižování dávek až do stavu placeba. Vhodnou lékovou formou se jeví tvrdé želatinové tobolky, ve kterých mohou být kromě diazepamu obsaženy i další adjuvantní léčiva z řady antipsychotik, antidepresiv a betablokátorů, zmírňujících abstinenční příznaky. Vzhledem k nízkým dávkám léčiv musí mít tobolky vyhovující obsahovou stejnoměrnost dle požadavků ČL 2017. V běžné lékárenské praxi se nepodařilo tomuto požadavku vyhovět. Při použití vhodného plniva a běžného kuchyňského mixéru je ale možné požadavek splnit. Výsledkem jsou tobolky s obsahem diazepamu v rozsahu 2,125 až 0,492 mg, určené ke snižování dávky o 15 %. Zvolená technologie zaručí způsobilost procesu, a je tedy schopna produkovat